UCB - Dusseldorf Stock Exchang (UNC DU) stock market data APIs
€234.842
0(0%)
as of December 16, 2025
Try our APIs with
free plan!
UCB - Dusseldorf Stock Exchang Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UNC.DU.
Prev. Close
234.842
Open
234.842
High
234.842
Low
234.842
52 wk Range
134.3572-260.3
Market Cap
18 821 M
Dividends (Yield)
0.015
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UCB - Dusseldorf Stock Exchang data using free add-ons & libraries
Get UCB - Dusseldorf Stock Exchang Fundamental Data
UCB - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UCB - Dusseldorf Stock Exchang News
New
UCB (ENXTBR:UCB): A Fresh Look at Valuation as Momentum Builds
UCB (ENXTBR:UCB) shares have caught more attention lately thanks to a mix of solid recent performance and strong momentum over the past month. Investors are watching closely to see if this trend conti...
CoreWeave, AstraZeneca, GSK, BYD, Tesla: Trending Stocks
Stocks to watch this morning include CoreWeave (CRWV), the NVIDIA (NVDA)-backed AI cloud scaler, which is rising after some big swings in recent weeks. In the pharmaceutical sector, AstraZeneca (AZN) ...
UCB Soars to Record as Rival MoonLake Crashes on Trial Data
(Bloomberg) -- Shares in Belgium’s UCB SA soared to a record, while rival MoonLake Immunotherapeutics is set to lose most of its value, after the latter announced late-stage trial data for an experi...
Recent Price Trend in UCB (UCBJY) is Your Friend, Here's Why
When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a tren...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
